Febuxostat
Overview
Febuxostat is a non-purine xanthine oxidase inhibitor for the treatment of chronic hyperuricaemia.
It is 2-[3-cyano-4-(2-methylpropoxy) phenyl]-4-methylthiazole-5-carboxylic acid. The empirical formula is C16H16N2O3S.
Categories
- 2 Analgesics, antipyretics, NSAIDs, antigout, and antirheumatics
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Febuxostat's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 40 to 40 mg | 40 (40) | 24 hourly | PO | This is the starting dose for hyperuricemia patients with gout. It can be taken with or without food. |
| 80 to 80 mg | 80 (80) | 24 hourly | PO | This is the dose for patients who do not achieve a serum uric acid less then 6mg/dl after 2 weeks with 40mg dose. It can be taken with or without food. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Febuxostat is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Febuxostat is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Febuxostat
Back to top
Previous Drug Generic - Next Drug Generic